PREVIOUS
✖
Emergency use approval in India
January 6 , 2021
1343 days
833
0
- The Drug Controller General of India (DCGI) has recommended the restricted Emergency Use Authorisation for COVISHIELD.
- COVISHIELD vaccine was developed by Serum Institute of India.
- It is developed by the University of Oxford and the British Pharmaceutical firm Astra Zeneca.
- In India, this vaccine is to be made and marketed by Pune Serum Institute of India.
- It is the first vaccine to be approved in India.
- India's Central Drugs Standard Control Organisation (CDSCO) has also reportedly recommended to the DGCI for granting the emergency use approval to the Bharat Biotech's Covaxin coronavirus vaccine.
- This makes that the Bharat Biotech's Covaxin the second vaccine to get marketing approval from the expert panel.
- Both the vaccines will have to be administered in two doses and they will have to be stored at 2-8° C.
Leave a Reply
Your Comment is awaiting moderation.